EMAIL THIS PAGE TO A FRIEND

Oncotarget

MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN.


PMID 25803229

Abstract

Intrahepatic cholangiocarcinoma (ICC) constitutes the second-most common primary hepatic malignancy. MicroRNAs (miRNAs) play important roles in the pathogenesis of ICC. However, the clinical significance of miR-21 levels in ICC remains unclear. Here, we investigated the role of miR-21 in ICC and found that its expression was significantly upregulated in serum of ICC patients. Serum miR-21 levels robustly distinguished ICC patients from control subjects. Further experiments showed that inhibition of miR-21 suppressed ICC cell proliferation in vitro and tumor growth in vivo. Specifically, inhibition of miR-21 induced cell cycle arrest and apoptosis. Moreover, PTPN14 and PTEN were identified as direct and functional targets of miR-21. Finally, we showed high expression levels of miR-21 were closely related to adverse clinical features, diminished survival, and poor prognosis in ICC patients. This study revealed functional and mechanistic links between miR-21 and tumor suppressor genes, PTPN14 and PTEN, in the pathogenesis of ICC. MiR-21 not only plays important roles in the regulation of cell proliferation and tumor growth in ICC, but is also a diagnostic and prognostic marker, and a potential therapeutic target for ICC.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB2700311
Anti-PTPN14 (C-terminal) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
1102974
Cetrimonium bromide, United States Pharmacopeia (USP) Reference Standard
C19H42BrN
D9026
Digoxigenin, analytical standard
C23H34O5
Y0000640
Digoxigenin, European Pharmacopoeia (EP) Reference Standard
C23H34O5
F9037
Formamide, ≥99.5% (GC), BioReagent, for molecular biology
CH3NO
221198
Formamide, ACS reagent, ≥99.5%
CH3NO
47671
Formamide, BioUltra, for molecular biology, ≥99.5% (T)
CH3NO
613339
Formamide solution, NMR reference standard, 90% in DMSO-d6 (99.9 atom % D), NMR tube size 3 mm × 8 in.
CH3NO
551384
Formamide solution, NMR reference standard, 90% in DMSO-d6 (99.9 atom % D), NMR tube size 5 mm × 8 in.
CH3NO
612707
Formamide solution, NMR reference standard, 45% in DMSO-d6 (99.9 atom % D), NMR tube size 3 mm × 8 in.
CH3NO
611891
Formamide solution, NMR reference standard, 45% in DMSO-d6 (99.9 atom % D), NMR tube size 5 mm × 8 in.
CH3NO
733784
Formamide solution, NMR reference standard, 90% in DMSO-d6 (99.9 atom % D), NMR tube size 10 mm × 8 in.
CH3NO
736201
Formamide solution, NMR reference standard, 90% in DMSO-d6 (99.9 atom % D), NMR tube size 5 mm × 8 in.
CH3NO
ARK2188
Hexadecyltrimethylammonium bromide, PharmaGrade, USP/NF, Manufactured under appropriate controls for pharma or biopharmaceutical production.
C19H42BrN
H9151
Hexadecyltrimethylammonium bromide, BioXtra, ≥99%
C19H42BrN
52365
Hexadecyltrimethylammonium bromide, BioUltra, for molecular biology, ≥99.0% (AT)
C19H42BrN
H6269
Hexadecyltrimethylammonium bromide, for molecular biology, ≥99%
C19H42BrN
52367
Hexadecyltrimethylammonium bromide, for ion pair chromatography, LiChropur
C19H42BrN
H5882
Hexadecyltrimethylammonium bromide, ≥98%
C19H42BrN
36932
Hexadecyltrimethylammonium bromide, analytical standard
C19H42BrN
52370
Hexadecyltrimethylammonium bromide, ≥96.0% (AT)
C19H42BrN
07883
Hexadecyltrimethylammonium bromide, puriss. p.a., matrix substance for MALDI-MS
C19H42BrN